The Association of Community Cancer Centers (ACCC) brings together cancer programs and practices united in commitment to advancing delivery and access to high-quality cancer care. ACCC understands the value patients place on receiving treatment in their home communities and supports its members and the entire oncology specialty in prioritizing equity, diversity, and inclusion in quality cancer care delivery and within the oncology workforce.
The U.S. Centers for Disease Control and Prevention defines health equity simply and clearly: Health equity is when everyone has the opportunity to be as healthy as possible.
Health equity is achieved when all individuals have the opportunity to reach their full health potential, and no one is held back from achieving this potential due to social position or other socially determined circumstances.
Across healthcare—and cancer care—we recognize the critical need to advance health equity to lessen and eliminate health disparities is recognized.
ACCC continues to develop resources and tools to better understand and support equity initiatives in cancer prevention and detection, diagnosis and treatment, access to clinical trials, survivorship and end-of-life care. Please continue to check this webpage for new updates on this important work.
For more information about this project, please contact Limaya Atembina, MSW, Program Manager, ACCC Provider Education.
Addressing disparities in prostate cancer requires the ability to recognize that care inequities exist and to commit to proven efforts to provide equitable care to all patients. This is not an easy undertaking—but an essential one for any healthcare team.
An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)
Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? (January 27, 2021)
Learn more about resources which already exist, successful models for pharmacist integration into oncology research teams, and the unique skills which pharmacists offer the interdisciplinary team. (October 30, 2020)
The ACORI Call to Action Summit’s Executive On September 13 and 14, 2021, ACCC, in collaboration with Stand Up to Cancer, hosted the ACORI Call to Action Summit: Activating Equity in Community Oncology Research, a virtual event that identified concrete strategies for engaging patients, caregivers, and their communities to strengthen oncology research across the United States. As a result, ACCC developed the ACORI Call to Action Executive Summary, a comprehensive overview of the action items co-developed by the Summit participants.
Hear from two authors of an ACCC/LUNGevity Foundation study that identified key areas of clinician need related to biomarker testing in NSCLC.
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so.
In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
Learn about the cultural and logistical barriers to end-of-life health equity and discover strategies that programs can implement to both address palliative care earlier in the care continuum and reduce health disparities.
We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Discover what steps cancer programs can take to build trust with patients from marginalized and underrepresented groups and ensure a more equitable and accessible healthcare environment.
Explore the barriers and challenges that LGBTQ+ patients with cancer face, and how cancer programs can make their care more inclusive.
Learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.
3, 2, 1, Go! Practical Solutions for Addressing Cancer Care Disparities
ACCC Community Oncology Research Institute
Eliminating Precision Medicine Disparities
The Role of Oncology Advanced Practitioners in Equitable Cancer Care Delivery
Real-World Lessons from COVID-19: Driving Oncology Care Forward (2021-22)
Community Oncology Can Close the Gap in Cancer Research (2020-21)
A critical component of reducing cancer mortality lies in achieving equity in care - STAT (statnews.com)
Oct 10, 2021
Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations
March 1, 2021
ASCO & ACCC Join Forces to Increase Participation of Racial and Ethnic Minority Populations in Cancer Treatment Trials
Jul 21, 2020
Statement by Association of Community Cancer Center's President Regarding Negative Long-Term Effect of Pandemic to Cancer Care
Jun 25, 2020
ACCC Statement on Recent Events Impacting our Communities
Jun 05, 2020